{"id":"clarithromycin-immediate-release-tablets","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This binding action prevents the translocation of the ribosome along the mRNA, thereby inhibiting the synthesis of proteins essential for bacterial growth and survival. As a result, clarithromycin exerts its bacteriostatic effect, ultimately leading to the death of the bacterial cell.","oneSentence":"Clarithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:06:15.098Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial exacerbation of chronic bronchitis"},{"name":"Mild to moderate adult and pediatric patients with acute maxillary sinusitis"}]},"trialDetails":[{"nctId":"NCT05845567","phase":"PHASE1","title":"The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)","status":"COMPLETED","sponsor":"Italfarmaco","startDate":"2022-03-21","conditions":"Drug Drug Interaction","enrollment":20},{"nctId":"NCT00648830","phase":"PHASE1","title":"Comparative Bioavailability Study of Clarithromycin 250 mg Tablets","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-05","conditions":"Healthy","enrollment":32},{"nctId":"NCT05716854","phase":"PHASE1","title":"Electrophysiological Effects of Potential QT Prolonging Drugs","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2023-03-21","conditions":"Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics","enrollment":44},{"nctId":"NCT02197884","phase":"PHASE1","title":"A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-07","conditions":"Healthy","enrollment":13},{"nctId":"NCT00648960","phase":"PHASE1","title":"Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-07","conditions":"Healthy","enrollment":64},{"nctId":"NCT00648128","phase":"PHASE1","title":"Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-03","conditions":"Healthy","enrollment":44},{"nctId":"NCT00645086","phase":"PHASE3","title":"Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis","status":"COMPLETED","sponsor":"Abbott","startDate":"2002-12","conditions":"Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).","enrollment":465}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ABT-268","Biaxin","clarithromycin"],"phase":"phase_3","status":"active","brandName":"clarithromycin immediate-release tablets","genericName":"clarithromycin immediate-release tablets","companyName":"Abbott","companyId":"abbott","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clarithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. Used for Community-acquired pneumonia, Acute bacterial exacerbation of chronic bronchitis, Mild to moderate adult and pediatric patients with acute maxillary sinusitis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}